* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1
Evolution of metal ions in biological systems wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Ribosomally synthesized and post-translationally modified peptides wikipedia , lookup
Expression vector wikipedia , lookup
Fatty acid metabolism wikipedia , lookup
Magnesium transporter wikipedia , lookup
Interactome wikipedia , lookup
Basal metabolic rate wikipedia , lookup
Ancestral sequence reconstruction wikipedia , lookup
Peptide synthesis wikipedia , lookup
Western blot wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
Protein purification wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Point mutation wikipedia , lookup
Two-hybrid screening wikipedia , lookup
Genetic code wikipedia , lookup
Metalloprotein wikipedia , lookup
Proteolysis wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Nutrition In Pediatric CRRT: what should we be doing? Michael Zappitelli, MD, MSc Montreal Children’s Hospital McGill University Health Center Montreal, Quebec, Canada Objectives • Nutrition in critical illness and AKI • Impact of CRRT on nutrition. • Recommendations. Critical Illness X No real prevention/treatment Acute Kidney Injury X Left with: 1) Modifying the negative effects of AKI 2) Providing adequate nutrition ??? Modify outcome??? Poorer outcome, increased mortality Critical Illness hormone changes -Insulin resist -Increase stress ↑ cytokines MALNUTRITION Uremia Acidosis Altered Glucose metab. Cytokines Altered substrate utilization CH2O: ↑hepatic gluconeogenesis (shift away from glycolysis) ↑lipogenesis - Inefficient glucose oxidation - Insulin resistance - Shift in use of amino acids: gluconeogenesis Impaired nutrient transport Inefficient/inadequate supply Impaired A.a. conversion ↓lipid oxidation Acute Kidney Injury Malnutrition • Delayed wound healing • Muscle wasting • Impaired organ function • Infection susceptibility • ?prolonged hospitalization Overfeeding • Hyperglycemia • Fatty Liver • Increased CO2 production. Want to avoid under- and over- feeding Critical Illness and Nutrition Admission • Children: high risk of malnutrition. • High basal metabolic rates. PICU discharge Hulst et al, Clinical Nutrition, 2004 • Limited energy reserves/reduced “stores” • The smaller the child, the higher the relative energy and protein needs • Children require nutrition for “maintenance” and for growth. • High (15-30%) baseline poor nutrition. Briassoulis et al, Nutrition, 2001 Malnutrition AND AKI + • Increased difficulty in nutrition provision. • Metabolic changes of AKI. • Children with AKI – increased risk of malnutrition (decline in wt SD scores) at PICU discharge. Hulst et al, J Nutritional Biochemistry, 2006 • RRT – increases nutritional losses. Nutrition and AKI • Problem: No evidence-based guidelines. • Difficulty to show effect on hard outcomes. • 1) 2) 3) 4) Recommendations based on Adult studies Known metabolic alterations with AKI Nutrition in critically ill children Measuring nutritional losses by RRT. Critical Illness – Energy needs • Negative energy balance = wt loss and growth compromised • RDA versus predictive equations vs direct measurement (indirect calorimetry). • No single predictive equation shown to accurately estimate REE. • - +/- 75% of true REE! AKI and energy needs • Controversial – AKI per se probably not affect energy expenditure. • Affected more by coexisting conditions. Indirect Calorimetry • Indirectly measures REE my measuring inspired O2 and expired CO2 – relates to “fuel use”. • Patient should be in “steady state”. • Not reliable with very high FiO2. • ETT and chest tubes leaks – not reliable. Indirect calorimetry AND CRRT • • IC: measure resting energy expenditure. Potential problem with CRRT HCO3/CO2 fluxes May affect IC measurements. IC may not be reliable? Hemofilter Effluent Dialysis fluid Critical Illness – Energy needs • Adults: 25-35 kcal/kg/day – probably need more in children. • Mean REE in literature: 35 to 60 kcal/kg/day (0.15-0.27 MJ/kg/day) • Almost no studies in AKI. Energy needs Increased REE: Fever Sepsis Post-prandial state Acute events (procedures, ventilatory changes) ASA, caffeine High temperature environment Decreased REE: Paralytics, sedatives Decreased temperature Avoid over and underfeeding Carbohydrates • Patients become hyperglycemic. • Insulin resistance, ↑hepatic gluconeogenesis. – Stress hormones – Inflammatory mediators and cytokines – Metabolic acidosis – Pre-existing hyperparathyroidism Effects of CRRT Glucose • There may be glucose loss with glucose “–” solutions (? as high as 40-80 g/day in adults). • BUT hyperglycemia is actually usually a problem – so probably not very significant. • If use glucose-solutions: use “physiologic” – avoid unnecessary shifts. Critical Illness & AKI - Lipids h LDL and VLDL • iHDL-Cholesterol Impaired Lipolysis • Lipid turnover is increased with critical illness. • FFA source of fuel for gluconeogenesis • So, need to give lipids Effects of CRRT • Lipid losses • Minimal/none Critical Illness – trace metals • - Deficiencies linked to: Lymphocyte dysfunction Cardiovascular dysfunction Platelet activity Antioxidant function Wound healing Effects of CRRT Losses Trace metals: Protein binding very high, so though MW is very small. But protein binding is altered, redistribution occurs, maybe more clearance. Different trace metals found to be low in critically ill patients, especially zinc and selenium. These are antioxidants. Consider replacing with additional supplementation. Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, unpublished We studied nutrient balance in critically ill children receiving CVVHD to: (1) determine the dialysis clearance of, and (2) quantify amino acid, trace metal and folate losses, and (3) calculate the extent to which CVVHD losses impact daily nutrient balance. • Prospective study, 5 days. • Inclusion: 1 mth to 21 years, about to be initiated on CRRT • Exclusion criteria: ESRD, prior dialysis therapy during admission, s/p Renal Tx, likely mortality within 24 hours. Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted Standard CVVHD: PRSIMA: M60 or M100 AN69 filter Qb = 2-4 ml/min/1.73msq, Qd = 2L/hour/1.73msq, Normocarb Citrate regional anticoaggulation + CaCl Data Collection: Daily: • ALL fluids in, ALL fluids out • Nutrition: EN, PN, blood products, citrate/calcium, etc • All amino acid, folate, zinc, selenium, copper, chromium, manganese contents LAB: BLOOD: Day 1 (peri CVVHD start), prefilter amino acids, folate, trace metals. Day 2: prefilter amino acids, folate, trace metals. Day 5: prefilter amino acids, folate, trace metals. Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted LAB: Day 2 and Day 5: 6 to 12 hr effluent collection: amino acids, folate, trace metals + total Nitrogen 6 to 12 hour urine collection: idem CVVHD and urine clearance calculated Grams/micrograms amino acid, folate, trace metal losses calculated Nutrient balances calculated Trace metal, folate and nitrogen concentrations in dialysis fluid (n=2), citrate (n=2), packed red cells (n=1) and fresh frozen plasma (n=1). Dialysis fluid Citrate Selenium (mcg/ml) Copper (mcg/ml) Chromium (mcg/ml) Zinc (mcg/ml) Manganese (mcg/ml) Folate (ng/ml) Nitrogen (g/ml) 0.0015 0 0.0002 0.01 0.00025 NA NA 0.0005 0 0.0107 0.03 0.00125 NA NA Packed red cells 0.039 0.20 0.0011 0.66 0.0014 3.1 0.004 Frozen plasma 0.097 0.97 0.0013 0.74 0.0004 14.8 0.011 Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted Selenium Copper Chromium Zinc Manganese Folate K1 Day 2 K Day 5 2 (ml/min/1.73m ) (ml/min/1.73m2) Serum concentrations_____________________ Initiation Day 2 Day 5 Reference range2 10.1±7.2, 9.5 0.4±0.3, 0.3 24.0±10.6, 25.4 4.2±4.1, 3.2 9.0±12.9, 4.6 29.4±54.9, 16.2 55±19, 49 88±21, 87 L 2±1, 2 66±44, 53 L 9±16, 4 H 16±12, 12 8.6±3.9, 7.2 0.54±0.46, 0.44 24.7±7.1, 26.0 4.0±2.4, 2.9 38.2±121.4, 5.1 15.6±3.2, 16.3 61±24, 59 110±27, 106 2±1, 2 68±28, 61 8±15, 3 H 10±4, 9 64±23, 63 104±27, 103 2±0.4, 2 76±38, 68 8±15, 3 H 8±2, 7 23 to 190 (µg/l) 90 to 190 (µg/dl) 0 to 2.1 (µg/l) 60 to 120 (µg/dl) 0 to 2 (µg/l) 5.4 to 40 (ng/l) Only selenium balance was negative on Days 2 and 5. Churchwell et al, NDT, 2007 Critically ill adults receiving CVVHD and CVVHDF Transmembrane clearances Much lower clearance of selenium and chromium Overall, trace metal clearance negligible (0.5 – 5.0 ml/min). Critical Illness - protein • Protein synthesis AND breakdown are increased: breakdown more increased. • Manifestation: proteolysis, net negative nitrogen balance, skeletal muscle wasting. • Nitrogen balance = Nin – Nout. • Generally goal is + NB = less protein catabolism ? = better outcome Critical Illness & AKI - protein - Reduced renal synthesis of amino acids - Factors related to critical illness (elevated stress hormones, increased hepatic gluconeogenesis, relative insulin resistance). Ferrando et al, Crit Care Med, 2007 - Redistribution of amino acids to areas of injury, for inflammation, gluconeogenesis - Losses AKI and protein • Protein synthesis CAN be increased by providing more amino acids. Bellomo et al, Int J of Artif Organs, 2002 Scheinkestel et al, Nutrition, 2003 • Still very difficult to achieve positive N balance. What amino acids should we give? • Essential and non-essential amino acids. • “non-essential” just means that the body produce them endogenously… but body has to “work” to generate these. • If only give large amounts of EAA: protein synthesis increases, NEAA depletion Glutamine and arginine • Supplementation thought to improve immune function and GI function. Arginine: - “immunomodulating” - Precursor to NO • Rats with I-R AKI: large amounts of Arg led to increased GFR ?due to increased NO. Glutamine: Neu et al – less sepsis with glutamine supplementation (J Peds 1997 131:691-699) Avenell, 2006 – meta-analysis, suggests publication bias. Effects of CRRT Losses Amino acids: mean size = 145 Da Affected by plasma concentration – glutamine is one of highest, so often highest losses. Affected by: Filter size, Qd, Qb, Qr. Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted CVVHD clearance of amino acids measured on Day 2 and Day 5 N=15 Amino Acid Day 2 (n=15) K1 CVVHD CVVHD Losses K Renal (n=2) 2 (ml/min/1.73m ) (mcg/kg/d) (ml/min/1.73m2) Mean±SD, Median Mean±SD, Median Mean Day 5 (n=9) K CVVHD CVVHD Losses K Renal (n=3) 2 (ml/min/1.73m ) (mcg/kg/d) (ml/min/1.73m2) Mean±SD, Median Mean±SD, Median Mean Tau Asp Thr Ser Asn Glu Gln Pro Gly Ala Cit Val Cys Met Ile Leu Tyr Phe Orn Lys His Arg 104.5±179.0, 32.9 335.8±483.7, 53.6 31.9±25.0, 22.6 29.1±25.6, 17.8 37.2±32.1, 32.3 9.4±10.6, 6.2 19.4±20.1, 13.2 38.3±32.7, 31.2 28.1±25.7, 18.0 26.1±24.6, 15.4 25.6±24.3, 15.9 24.8±22.0, 14.8 27.4±54.5, 8.6 18.0±19.9, 8.2 29.9±29.8, 17.3 22.9±20.9, 13.6 22.2±23.3, 10.7 23.9±20.8, 12.9 8.4±8.7, 12.9 7.7±9.0, 2.8 13.2±15.8, 10.0 15.8±17.1, 8.0 77.8±111.2, 24.2 234.0±349.8, 51.1 38.8±25.1, 29.8 34.6±27.7, 22.3 35.5±19.8, 34.3 6.1±5.0, 3.8 85.4±152.9, 21.2 37.5±21.9, 27.3 35.3±30.2, 19.8 37.9±38.8, 25.2 39.3±50.4, 25.7 39.1±37.3, 25.1 34.7±29.9, 44.3 26.8±31.1, 17.2 38.6±34.7, 22.1 32.2±28.8, 22.7 36.5±41.3, 21.4 34.9±29.7, 26.4 91.0±249.7, 10.6 108.4±299.5, 9.6 33.4±66.3, 15.7 45.8±68.6, 8.6 8.4±11.1, 4.8 3.9±4.1, 3.2 15.7±18.5, 9.9 8.1±8.6, 5.7 7.7±8.1, 4.5 2.7±4.0, 1.8 47.4±63.7, 23.0 24.3±22.2, 17.6 16.0±16.1, 7.5 23.4±21.2, 13.5 2.8±4.5, 1.3 16.8±13.4, 12.7 0.8±1.2, 0.5 5.9±13.5, 12.7 6.0±5.7, 4.3 11.6±9.2, 7.8 9.2±13.5, 4.3 18.4±23.1, 7.8 3.4±5.0, 1.0 10.0±11.1, 4.4 8.0±15.9, 2.8 11.4±23.4, 3.5 1.0 2.6 4.1 3.6 9.8 0.6 2.2 0.2 3.9 5.2 4.1 5.2 0.5 3.6 6.9 3.9 4.4 4.5 0.3 0.3 0.7 1.8 4.5±5.4, 1.8 5.6±4.4, 2.6 11.9±5.9, 12.0 6.0±3.3, 5.0 5.0±3.4, 5.3 1.6±0.7, 1.7 44.2±30.7, 34.5 19.4±11.2, 20.5 12.0±7.1, 14.1 20.0±11.5, 24.1 1.5±1.1, 1.4 14.4±6.9, 13.9 1.3±1.1, 1.1 2.2±1.8, 2.2 5.4±2.7, 4.3 10.3±5.2, 10.9 5.6±2.7, 5.2 11.3±6.2, 10.1 2.5±3.4, 1.4 8.7±8.9, 5.6 4.5±3.8, 5.1 6.0±4.8, 4.1 2.1 12.0 18.9 9.2 28.6 1.0 0.7 0.8 12.9 6.9 5.7 5.5 5.2 5.1 6.6 4.4 10.5 7.0 0.7 0.9 12.1 6.2 Combined results of clearance of essential amino acids by CRRT. Zappitelli et al (submitted) and Maxvold et al, Critical Care, 2000 (n=6). 60 50 40 K ml/min/1.73m2 30 20 10 0 Thr Glu Gln Pro Gly Ala Val Met Phe Lys His Arg Amino Acids Several studies, adult and child: ~ 10-20% intake “lost” through hemofilter. Both studies: Highest losses with Glutamine/Glutamic acid Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted Protein and energy intake and output at CVVHD1 initiation, Day 2 and Day 5. Protein intake (g/kg/d) N balance (g/kg/d) Caloric intake (kcal/kg/d) Caloric balance (kcal/kg/day) CVVHD initiation (N=15) Mean±SD, Median Day 2 (N=15) Mean±SD, Median 1.98±1.24, 1.75 2.04±1.02, 2.09 1.85±0.60, 2.08 NA -0.88±1.60, -0.22 -0.23±0.19, -0.24 32.6±27.6, 23.8 40.3±22.3, 33.6 43.2±18.4, 42.7 -0.4±25.4, -8.0 +7.7±21.7, +1.5 Day 5 (N=9) Mean±SD, Median +10.6±17.7, +10.8 Maxvold et al, Crit Care Med, 2000 Protein intake was 1.5 g/kg/day – Negative nitrogen balance It’s not easy to achieve a positive nitrogen balance. Logic: bigger filter, higher Qd or Quf = increased clearance Does increasing protein intake help? • Scheinkestel et al. 1. Nutrition, 2003 In 11 critically ill adults on CRRT, protein intake 2.5 g/kg/day led to a) normal amino acid levels and b) positive nitrogen balance. 2. Nutrition, 2003 50 critically ill adults on CRRT: 1.5 vs 2.0 vs 2.5 g/kg/day. NB related to protein intake. NB related to hospital stay Protein intake 2.5 g/kg/d: improved survival! Effects of CRRT Losses Water soluble vitamins: Vit C - Limit 200 mg/d as precursor to Oxalic acid Vit B1 (thiamine) - Altered Energy Metabolism, h Lactic Acid, Tubular damage Folate - Anemia These are antioxidants – “good stuff” Consider replacing. CRRT-Vitamins Amino acid, trace metal and folate clearance by continuous renal replacement therapy in critically ill children. Zappitelli et al, submitted Clearance folate: about 16 ml/min/1.73m2 on Days 2 and 5 16 14 12 10 Serum folate 8 level (ng/ml) 6 4 2 0 * * Pre CRRT Day 2 Day of CRRT Day 5 What are we doing? Protein and calorie prescription for children and young adults receiving CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry group. Zappitelli et al, CCM, accepted. We reviewed data from the Prospective Pediatric CRRT (ppCRRT) Registry to (1) evaluate current protein and caloric prescription practices for critically ill children and young adults with AKI receiving CRRT and (2) evaluate the factors associated with over- and under-prescription of protein and calories. Retrospective study ppCRRT centers with >=10 patients Inclusion: eGFR<75 at CRRT start and required protein and caloric data. Exclusion: toxin and/or metabolic disorders. Data Protein and caloric prescription at every circuit start. Calculated REE Protein and calorie prescription for children and young adults receiving CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry group. Zappitelli et al, submitted. 2 1 0 Protein intake (g/kg/day) 3 4 5 Daily change in protein prescription during treatment with CRRT. 1 2 3 4 5 6 excludes outside values Day of CRRT 7 8 9 10 Protein and calorie prescription for children and young adults receiving CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry group. Zappitelli et al, submitted. 75 50 0 25 Caloric Intake (kcal/kg/day) 100 125 150 Daily change in caloric prescription during treatment with CRRT. 1 2 3 4 5 6 excludes outside values Day of CRRT 7 8 9 10 Protein and calorie prescription for children and young adults receiving CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry group. Zappitelli et al, submitted. Characteristics (N) N=195 Gender Males (111) Females (84) p-value1 Age Group ≤ 1 year (35) 1 to ≤13 years (95) >13 years (65) p-value MODS (155) No MODS (40) p-value Survival Survivors (117) Non-survivors (78) p-value CRRT indication Electrolytes (31) Fluid overload (66) Electrolytes and fluid overload (98) p-value Protein intake (g/kg/day) Initial Maximal 1.4, 1.0[1.4] 1.3, 1.0[1.2] 0.7 2.0, 1.6[1.6] 1.9, 1.8[1.5] 0.9 1.5, 1.8[1.5] 1.3, 1.0[1.2] 1.4, 1.0[1.0] 0.09 2.5, 2.4[2.3] 2.0, 1.9[1.5] 1.6, 1.3[1.1] 0.009* 1.3, 1.0[1.2] 1.5, 1.0[0.8] 0.1 1.9, 1.8[1.5] 2.0, 1.3[1.7] 0.2 1.4, 1.0[1.2] 1.3, 1.0[1.3] 0.6 2.0, 1.6[1.5] 1.8, 1.8[1.7] 0.9 1.2, 1.0[0.9] 1.6, 1.2[1.2] 1.2, 1.0[1.3] 1.6, 1.4[1.1] 2.1, 1.8[1.8] 2.0, 1.8[1.6] 0.07 0.2 All groups: -Maximal protein>initial Multivariate predictors of maximal protein intake - Younger age - Higher initial protein Rx - #CRRT days Protein Rx >2g/kg/day in 40% AKI and nutrition • Bellomo’s “cardinal rules” (Bellomo, Blood Purif, 2002): 1) The presence of renal disease should never lead to restriction in nutritional support. 1) Protein catabolism due to MODS or severe illness FAR outweighs that due to AKI. 3) Effect of CRRT on catabolism is small. Synthesis Nutritional parameter Nutrition modality - Early enteral feeding, will often require parenteral nutrition Energy - Approximately 25-40% above basal metabolic needs as measured by metabolic cart or estimated with equations (de Klerk et al, Int Care Med, 2002). -20 to 25% as carbohydrates (insulin as needed) 30 to 40% lipid formulations (20% lipid emulsions) 40 to 50% protein Protein - 2 to 2.5 g/kg/day with AKI (Multiple references) - Increase intake if on CRRT (by 20%) Vitamins - Daily recommended intake - Monitor serum folate, water soluble vitamin levels ± replacement (? 2X RDA) Trace elements - Daily recommended intake; consider extra zinc and selenium Monitoring -Resting energy expenditure, nitrogen balance, electrolytes, vitamins, trace elements Consider - Glutamine Synthesis 1. Assure that any effects of CRRT on nutrition are being addressed. 2. Use CRRT initiation to review nutritional management. 3. Daily reassessment. 4. Multidisciplinary approach. Acknowledgements Dialysis Solutions Inc. Baxter Healthcare •Stuart Goldstein •ppCRRT registry authors/collaborators •Timothy Bunchman •Norma Maxvold